Expression, regulation and function of trail in atherosclerosis

被引:60
作者
Kavurma, Mary M. [1 ]
Bennett, Martin R. [2 ]
机构
[1] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia
[2] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge CB2 2QQ, England
关键词
D O I
10.1016/j.bcp.2007.10.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Atherosclerosis is a condition where vascular smooth muscle cells (VSMCs), inflammatory Received cells, lipids, cholesterol and cellular waste accumulate in the inner lining of an artery, producing a fibro-fatty plaque and resulting in the thickening of the arterial wall. The tumor necrosis factor (TNF) family of cytokines plays a major role in the progression of atherosclerosis. Recently, TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily, has been implicated in the development of atherosclerosis since it has been detected in normal and diseased atherosclerotic tissue. Not only is TRAIL involved in apoptosis and immune regulation, recent studies have provided a new function of TRAIL on vascular cells, such that TRAIL can promote endothelial cell (EC) and VSMCs migration and proliferation. In addition, TRAIL is implicated in regulating vascular tone. This review discusses our current understanding of TRAIL expression, regulation and function, and summarises the recent data implicating a role for TRAIL in atherosclerosis. Crown Copyright (c) 2007 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1441 / 1450
页数:10
相关论文
共 86 条
  • [1] TRAIL-induced apoptosis in human vascular endothelium is regulated by phosphatidylinositol 3-kinase/Akt through the short form of cellular FLIP and Bcl-2
    Alladina, SJ
    Song, JH
    Davidge, ST
    Hao, CH
    Easton, AS
    [J]. JOURNAL OF VASCULAR RESEARCH, 2005, 42 (04) : 337 - 347
  • [2] Safety and antitumor activity of recombinant soluble Apo2 ligand
    Ashkenazi, A
    Pai, RC
    Fong, S
    Leung, S
    Lawrence, DA
    Masters, SA
    Blackie, C
    Chang, L
    McMurtrey, AE
    Hebert, A
    DeForge, L
    Koumenis, IL
    Lewis, D
    Harris, L
    Bussiere, J
    Koeppen, H
    Shahrokh, Z
    Schwall, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 155 - 162
  • [3] Functional expression of NOS 1 in vascular smooth muscle
    Brophy, CM
    Knoepp, L
    Xin, JD
    Pollock, JS
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (03): : H991 - H997
  • [4] Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway
    Chaudhary, PM
    Eby, M
    Jasmin, A
    Bookwalter, A
    Murray, J
    Hood, L
    [J]. IMMUNITY, 1997, 7 (06) : 821 - 830
  • [5] A measurement of bank efficiency, ownership and productivity changes in Taiwan
    Chen, TY
    Yeh, TL
    [J]. SERVICE INDUSTRIES JOURNAL, 2000, 20 (01) : 95 - 109
  • [6] Choi EA, 2003, CANCER RES, V63, P5299
  • [7] Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis
    Clarke, Murray C. H.
    Figg, Nichola
    Maguire, Janet J.
    Davenport, Anthony P.
    Goddard, Martin
    Littlewood, Trevor D.
    Bennett, Martin R.
    [J]. NATURE MEDICINE, 2006, 12 (09) : 1075 - 1080
  • [8] Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro
    Corallini, Federica
    Celeghini, Claudio
    Rizzardi, Clara
    Pandolfi, Assunta
    Di Silvestre, Sara
    Vaccarezza, Mauro
    Zauli, Giorgio
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 212 (01) : 89 - 95
  • [9] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture
    Di Pietro, R
    Mariggiò, MA
    Guarnieri, S
    Sancilio, S
    Giardinelli, A
    Di Silvestre, S
    Consoli, A
    Zauli, G
    Pandolfi, A
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 97 (04) : 782 - 794
  • [10] Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L
    Di Pietro, R
    Zauli, G
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2004, 201 (03) : 331 - 340